Two fixed term postdoc positions (2 years, extendable) are available at Centre for Molecular Medicine Norway (NCMM)
24.2.2020Two fixed term postdoc positions (2 years, extendable) are available at Centre for Molecular Medicine Norway (NCMM). We welcome applications both from recent PhD graduates and more experienced scientists. Experimentalists, computer scientists and hybrids alike are encouraged to apply. Researchers aiming for academic principal investigator positions in the future are encouraged to apply for independent funding during their first year in NCMM.
The aim of the Haapaniemi group is to build a gene editing platform that
can be used to correct patient-specific mutations in ex vivo cell
therapies for genetic immune and other rare childhood diseases. We will
use high-throughput biology techniques to optimize,
develop and understand the CRISPR-Cas system that forms the base of the
platform, and develop and implement methods to evaluate its safety in a
clinical setting. We will use the modified gene editing technologies
for the benefit of the patients in the Nordic
hospitals
.
The aim of the Saarela group is to identify novel genetic causes for
rare and complex immune and hematological diseases and improve their
diagnostics and treatment. We use modern genetic and informatics
methods, including deep learning, to analyze genomics
and clinical data, as well as molecular genetics and cell biology
approaches to understand molecular bases of the diseases and normal
immune function. We will also use NGS based methods to identify
molecular diagnosis for patients suffering from rare genetic
disorders to enable accurate prediction of disease course, targeted
treatment and genetic counselling.
Link to the whole job description: